M 1121 is a potent, orally bioavailable small molecule inhibitor that disrupts the menin-MLL protein-protein interaction. It demonstrates robust anti-tumor activity in preclinical models, achieving complete and durable regression in vivo, and is a key research tool for studying MLL-rearranged leukemias.
Molecular Weight:
793.01
CAS Number:
[2377337-93-2]
Formula:
C42H57FN6O6S
Target:
Others,Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted
